Cita APA (7a ed.)
Emiloju, O. E., Zhu, M., Xie, H., Jin, Z., Sinicrope, F. A., & Hubbard, J. M. (2023). Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer. Current Treatment Options in Oncology, 24(12), 1739-1758.
Cita Chicago Style (17a ed.)
Emiloju, Oluwadunni E., Mojun Zhu, Hao Xie, Zhaohui Jin, Frank A. Sinicrope, y Joleen M. Hubbard. "Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer." Current Treatment Options in Oncology 24, no. 12 (2023): 1739-1758.
Cita MLA (9a ed.)
Emiloju, Oluwadunni E., et al. "Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer." Current Treatment Options in Oncology, vol. 24, no. 12, 2023, pp. 1739-1758.
Precaución: Estas citas no son 100% exactas.